Metabolic syndrome and its association with colorectal cancer: A review

American Journal of the Medical Sciences

Volumn 341, Issue 3, 2011, Pages 227-231

  Siddiqui, Ali A ^a,b  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Colorectal cancer; Hyperinsulinemia; Metabolic syndrome; Obesity

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN C; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; BLOOD PRESSURE; BODY MASS; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CLINICAL ASSESSMENT; COLORECTAL CANCER; DISEASE ASSOCIATION; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79952072918     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181df9055     Document Type: Article

References (54)

1. Zimmet P, Magliano D, Matsuzawa Y, et al. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005;12:295-300.
2. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 2003;35:694-704. (Pubitemid 38058173)
3. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995;6:164-79.
4. Friedenreich CM. Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomarkers Prev 2001;10:287-301. (Pubitemid 32703212)
5. Spence RR, Heesch KC, Brown WJ. A systematic review of the association between physical activity and colorectal cancer risk. Scand J Med Sci Sports 2009;19:764-81.
6. Slattery ML, Murtaugh M, Caan B, et al. Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control 2004;15:863-72. (Pubitemid 39663862)
7. Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut 2006;55:285-91. (Pubitemid 43117290)
8. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:920-31. (Pubitemid 44018922)
9. Schoen RE, Tangen CM, Kuller LH, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999;91:1147-54. (Pubitemid 29330553)
10. Almendingen K, Hofstad B, Vatn MH. Does high body fatness increase the risk of presence and growth of colorectal adenomas followed up in situ for 3 years? Am J Gastroenterol 2001;96:2238-46. (Pubitemid 32660924)
11. Otani T, Iwasaki M, Ikeda S, et al. Serum triglycerides and colorectal adenoma in a case-control study among cancer screening examinees (Japan). Cancer Causes Control 2006;17:1245-52. (Pubitemid 44772824)
12. Stadler J, Yeung KS, Furrer R, et al. Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer. Cancer Lett 1988;38:315-20. (Pubitemid 18060001)
13. Tocchi A, Ciani R, Cerroni M, et al. Significance of biliary lithiasic pathology in the etiopathogenesis of carcinoma of the large intestine [in Italian]. Chir Ital 1983;35:898-910.
14. Yamada K, Araki S, Tamura M, et al. Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. Int J Epidemiol 1998;27:794-8. (Pubitemid 28504966)
15. Chung YW, Han DS, Park YK, et al. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis 2006;38:668-72. (Pubitemid 44356269)
16. Trevisan M, Liu J, Muti P, et al. Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev 2001; 10:937-41. (Pubitemid 32844900)
17. Bayerdorffer E, Mannes GA, Richter WO, et al. Decreased highdensity lipoprotein cholesterol and increased low-density cholesterol levels in patients with colorectal adenomas. Ann Intern Med 1993;118: 481-7. (Pubitemid 23085789)
18. Park SK, Joo JS, Kim DH, et al. Association of serum lipids and glucose with the risk of colorectal adenomatous polyp in men: a case-control study in Korea. J Korean Med Sci 2000;15:690-5.
19. Wang YY, Lin SY, Lai WA, et al. Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population. J Gastroenterol Hepatol 2005;20:1410-5.
20. Bostick RM, Potter JD, Kushi LH, et al. Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 1994;5:38-52. (Pubitemid 24066592)
21. Ahmed RL, Schmitz KH, Anderson KE, et al. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006;107:28-36. (Pubitemid 43941640)
22. Bowers K, Albanes D, Limburg P, et al. A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. AmJ Epidemiol 2006;164:652-64. (Pubitemid 44453494)
23. Meigs JB, D'Agostino RB Sr, Wilson PW, et al. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997;46:1594-600. (Pubitemid 27411235)
24. Hanley AJ, Karter AJ, Festa A, et al; Insulin Resistance Atherosclerosis Study. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Diabetes 2002;51:2642-7. (Pubitemid 34827418)
25. Chang CK, Ulrich CM. Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients. Diabetologia 2003;46:595-607. (Pubitemid 36808179)
26. Khaw KT, Wareham N, Bingham S, et al. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev 2004;13:915-9. (Pubitemid 38756700)
27. Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis Br J Cancer 2001;84:417-22. (Pubitemid 32154439)
28. Stamp D, Zhang XM, Medline A, et al. Sucrose enhancement of the early steps of colon carcinogenesis in mice. Carcinogenesis 1993;14: 777-9. (Pubitemid 23150019)
29. Caderni G, Bianchini F, Mancina A, et al. Effect of dietary carbohydrates on the growth of dysplastic crypt foci in the colon of rats treated with 1,2-dimethylhydrazine. Cancer Res 1991;51:3721-5.
30. Jass JR. Diet, butyric acid and differentiation of gastrointestinal tract tumours. Med Hypotheses 1985;18:113-8. (Pubitemid 16256487)
31. Yang R, Arem R, Chan L. Gastrointestinal tract complications of diabetes mellitus. Pathophysiology and management. Arch Intern Med 1984;144:1251-6. (Pubitemid 14121078)
32. Rafter JJ, Child P, Anderson AM, et al. Cellular toxicity of fecal3 water depends on diet. Am J Clin Nutr 1987;45:559-63. (Pubitemid 17046210)
33. Rafter JJ, Eng VW, Furrer R, et al. Effects of calcium and pH on the mucosal damage produced by deoxycholic acid in the rat colon. Gut 1986;27:1320-9. (Pubitemid 17175680)
34. Dukas L, Willett WC, Colditz GA, et al. Prospective study of bowel movement, laxative use, and risk of colorectal cancer among women. Am J Epidemiol 2000;151:958-64. (Pubitemid 30463574)
35. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005;97:1679-87. (Pubitemid 41672234)
36. Platz EA, Hankinson SE, Rifai N, et al. Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States). Cancer Causes Control 1999;10:379-86. (Pubitemid 29454314)
37. Baserga R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 1995;55:249-52.
38. Sell C, Baserga R, Rubin R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res 1995;55:303-6.
39. Guo YS, Narayan S, Yallampalli C, et al. Characterization of insulinlike growth factor I receptors in human colon cancer. Gastroenterology 1992;102:1101-8.
40. Warren RS, Yuan H, Matli MR, et al. Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J Biol Chem 1996;271:29483-8. (Pubitemid 26382669)
41. Bjork J, Nilsson J, Hultcrantz R, et al. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand. J Gastroenterol 1993;28:879-84. (Pubitemid 23294761)
42. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992;65:311-20.
43. Underwood LE, Thissen JP, Lemozy S, et al. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 1994;42: 145-51. (Pubitemid 24336142)
44. Powell DR, Suwanichkul A, Cubbage ML, et al. Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J Biol Chem 1991;266:18868-76. (Pubitemid 21908164)
45. La Vecchia C, Negri E, Decarli A, et al. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1997;6: 1007-10. (Pubitemid 28007409)
46. Le Marchand L, Wilkens LR, Hankin JH, et al. A case-control study of diet and colorectal cancer in a multiethnic population in Hawaii (United States): lipids and foods of animal origin. Cancer Causes Control 1997;8:637-48. (Pubitemid 27330497)
47. Will JC, Galuska DA, Vinicor F, et al. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 1998;147:816-25. (Pubitemid 28244386)
48. Kaaks R, Toniolo P, Akhmedkhanov A, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000;92:1592-600.
49. Bonser AM, Garcia-Webb P. C-peptide measurement: methods and clinical utility. Crit Rev Clin Lab Sci 1984;19:297-352.
50. Stocks T, Lukanova A, Johansson M, et al. Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond) 2008;32:304-14. (Pubitemid 351271779)
51. Sturmer T, Buring JE, Lee IM, et al. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiol Biomarkers Prev 2006;15:2391-7. (Pubitemid 46048295)
52. Ma J, Giovannucci E, Pollak M, et al. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 2004; 96:546-53. (Pubitemid 38559579)
53. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 2007;86:S836-42.
54. Pais R, Silaghi H, Silaghi AC, et al. Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol 2009;15:5141-8.